Skip to content

The comparison of efficacy between the anterior femoral cutaneous nerve block and adductor canal block with the infiltration of the interspace between the popliteal artery and posterior capsule of the knee (iPACK) block versus Local infiltration of analgesia when combined with Continuous adductor canal block after Total knee arthroplasty: A randomized control trial

The comparison of efficacy between the anterior femoral cutaneous nerve block and adductor canal block with the infiltration of the interspace between the popliteal artery and posterior capsule of the knee (iPACK) block versus Local infiltration of a

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20191009006
Enrollment
Unknown
Registered
2019-10-09
Start date
2019-10-09
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OA Knee going on total knee arthroplasty &#45

Interventions

Single&#45
shot anterior femoral cutaneous nerve block and adductor canal block with iPACK block is perform by 0.25% Chirocaine 60 ml&#44
epinephrine 0.3 mg and ketorolac 30 mg The sham of local infiltration analgesia is done by NSS intra&#45
operatively. Continuous adductor canal block under ultrasound guidance is performed by injecting 0.25% levobupivacaine 20 ml and followed by 0.15% levobupivacaine 5 ml/hr for 60 hours ,Single&#45
shot sham anterior femoral cutaneous nerve block and adductor canal block with iPACK block under ultrasound&#45
guided is performed by injecting of 0.9% NSS 5 ml each blocks. Local infiltration analgesia is performed intra&#45
operatively. The cocktail consists of Levopupivacaine 150 mg&#44
and Adrenaline 0.3 mg combined with NSS 60 ml. Continuous adductor canal block under ultrasound guidance is performed by injecting 0.25% levobupivacaine 20 ml and followed by 0.15% levobupivacaine 5 m
Experimental Procedure/Surgery,Experimental Procedure/Surgery
Anterior femoral cutaneous nerve block and adductor canal block with iPACK block,Local infiltration analgesia

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patient who was scheduled for total knee arthroplasty at King Chulalongkorn Memorial Hospital ASA class 1 to 3 ASA class 1 A normal healthy patient ASA class 2 A patient with mild systemic disease Mild diseases only without substantive functional limitations ASA class 3 A patient with severe systemic disease but not threaten to life Body mass index BMI between 18 to 40 kg m2

Exclusion criteria

Exclusion criteria: refuse to participate this study unable to cooperate or cognitive impairment eg dementia allergy to any drug in this study contraindication to neuraxial anesthesia eg coagulopathy contraindication to NSAIDs Ketorolac and Celebrex in this study chronic opioids use or diagnosed of neuropathic pain unable to performed Time up and go test

Design outcomes

Primary

MeasureTime frame
postoperative pain score 24 hours Numerical pain rating scale

Secondary

MeasureTime frame
postoperative pain score of anterior knee pain at rest 6, 24, 48 hours and 3, 5 days and 1, 2 weeks and 1, 2, 3 months Numerical pain rating scale,postoperative pain score of anterior knee pain on movement 6, 24, 48 hours and 3, 5 days and 1, 2 weeks and 1, 2, 3 months Numerical pain rating scale,postoperative pain score of posterior knee pain at rest 6, 24, 48 hours and 3, 5 days and 1, 2 weeks and 1, 2, 3 months Numerical pain rating scale ,postoperative pain score of posterior knee pain on movement 6, 24, 48 hours and 3, 5 days and 1, 2 weeks and 1, 2, 3 months Numerical pain rating scale,postoperative opioids consumption 12, 24, 48 hours Milligram of Morphine Consumption,Degree of knee flexion and extension Postoperative 0, 1, 2 Days Degree of range of motion,Timed up and go test Postoperative 1, 2 days Rehabilitation after surgery,Postoperative Complication Postoperative 0, 1, 2 Days Postoperative Nausea Vomiting, Dizziness, Fall, Sleep disturbance,Length of stay Postoperative to discharge out of hospital hours,Patient satisfaction Postoperative day 2 Satisfactory score (1-10)

Countries

Thailand

Contacts

Public ContactWirinaree Kampitak

unaffiliated

nutong127@yahoo.com+6689-9955-666

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026